FMD has reduced manufacturing capacity by 10%, says BGMA
The falsified medicines directive (FMD) has reduced manufacturing capacity by 10%, British Generics Manufacturers Association (BGMA) director general Warwick Smith has claimed.
The falsified medicines directive (FMD) has reduced manufacturing capacity by 10%, British Generics Manufacturers Association (BGMA) director general Warwick Smith has claimed.